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Volume 61, Number 2 Abstracts 569the initial results reported in 2006 (Mas JL et al, N Engl J Med
2006;355:1660-71). At that time the authors reported a lower periproce-
dural stroke rate with CEA than with CAS. The current study focuses on
long-term follow-up of the patients and is designed to clarify the durability
of the two procedures with regard to stroke prevention. There was a mean
follow-up of 7.1 years (interquartile range, 5.1-8.8 years; maximum,
12.4 years). The primary endpoint was a composite of any ipsilateral stroke
after randomization or any procedural stroke or death. The primary
endpoint occurred in 30 patients in the stenting group compared with 18
patients in the endarterectomy group. Cumulative probabilities of this
outcome were 11.0% (95% CI, 7.9-15.2) vs 6.3% (4.0-9.8) in the endarter-
ectomy group at the 5-year follow-up point (hazard ratio, 1.85; 1.00-3.40;
P ¼ .04) and 11.5% (8.2-15.9) vs 7.6% (4.9-11.8; hazard ratio, 1.70; 0.95-
3.06; P ¼ .07) at the 10-year follow-up time. There was no difference
observed between treatment groups in the rates of ipsilateral stroke beyond
the procedural period, severe recurrent carotid restenosis ($70%) or occlu-
sion, death, myocardial infarction, and revascularization procedures.
Comment: The study presents long-term information on the dura-
bility of CAS vs CEA in preventing stroke following the periprocedural
period. Previously the CREST investigators have also shown that at 2-years
rates of restenosis following CEA and CAS are similar (Lal BK et al, Lancet
Neurol 2012;11:755-63). Clearly both procedures can be durable. For CAS
to be more widely accepted by both physicians and patients, periprocedural
stroke risk must be brought down to the same level of that as CEA.Meta-Analysis and Meta-Regression Analysis of Biomarkers
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Conclusions: There are many biomarkers that are dysregulated in pa-
tients with abdominal aortic aneurysm (AAA) but their clinical value has yet
to be established.Summary: There have been a number of studies on systemic and
local levels of biomarkers in patients with AAA that have yielded conﬂict-
ing results. Previous meta-analysis in patients with AAA have identiﬁed
increased levels of circulating ﬁbrinogen, D-dimer and thrombin-anti-
thrombin III complex in patients with AAA. In addition there has
been a signiﬁcant correlation between aortic diameter and D-dimer level
(Sidloff D et al, J Vasc Surg 2014; 59:528-35.e4). In addition to these
haematologic markers previously studied there are additional potential
biomarkers related to other processes that involve aneurysm formation.
The aim of the present study therefore was to undertake a systematic re-
view and, when possible, meta-analysis and meta-regression of studies
comparing the clinical value of alternative biomarkers for AAA such as
matrix metalloproteinases (MMPs), inﬂammatory markers, acute-phase
reactants and lipids. The authors reviewed literature from 106 studies.
Meta-analysis demonstrated a signiﬁcant difference between matrix met-
alloproteinases (MMP) 9, tissue inhibitor of MMP 1, interleukin (IL) 6,
C-reactive protein (CRP), a1-antitrypsin, triglycerides, lipoprotein (a),
apolipoprotein A and high-density lipoprotein in patients with and
without AAA. Meta-analysis was not possible for MMP-2 in aortic tissue,
tumor necrosis factor a, osteoprotegerin, osteopontin, interferon g,
intercellular cell adhesion molecule 1 and vascular cell adhesion mole-
cule 1. However, systematic review suggested an increase in these bio-
markers in patients with AAA. Meta-regression analysis also identiﬁed
a linear correlation between aortic diameter and C-reactive protein
(CRP) level.
Comment: The data reﬂect the fact that formation of an AAA is a
complex biochemical event. Biomarkers can potentially be used clinically
in combination with markers of stress and strain on the aneurysm wall to
identify patients at risk for aneurysm rupture and to assess the effects of
medical managements on aneurysm growth and risk of rupture. Hopefully
this will be the focus of future research. It is likely to keep biostatisticians
busy for quite some time.
